-
1دورية أكاديمية
المؤلفون: Codarri Deak, L., Nicolini, V., Hashimoto, M., Karagianni, M., Schwalie, P.C., Lauener, L., Varypataki, E.M., Richard, M., Bommer, E., Sam, J., Joller, S., Perro, M., Cremasco, F., Kunz, L., Yanguez, E., Hüsser, T., Schlenker, R., Mariani, M., Tosevski, V., Herter, S., Bacac, M., Waldhauer, I., Colombetti, S., Gueripel, X., Wullschleger, S., Tichet, M., Hanahan, D., Kissick, H.T., Leclair, S., Freimoser-Grundschober, A., Seeber, S., Teichgräber, V., Ahmed, R., Klein, C., Umaña, P.
المصدر: Nature, vol. 610, no. 7930, pp. 161-172
مصطلحات موضوعية: Antibodies, Blocking/immunology, Blocking/pharmacology, Blocking/therapeutic use, B7-H1 Antigen/antagonists & inhibitors, B7-H1 Antigen/immunology, CD8-Positive T-Lymphocytes/cytology, CD8-Positive T-Lymphocytes/drug effects, CD8-Positive T-Lymphocytes/immunology, Infections/drug therapy, Infections/immunology, Interleukin-2/immunology, Interleukin-2/pharmacology, Interleukin-2/therapeutic use, Interleukin-2 Receptor alpha Subunit/agonists, Neoplasms/drug therapy, Neoplasms/immunology, Programmed Cell Death 1 Receptor/antagonists & inhibitors, Receptors, Interleukin-2/agonists
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36171284; info:eu-repo/semantics/altIdentifier/eissn/1476-4687; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_D3A4E38D932D3; https://serval.unil.ch/notice/serval:BIB_D3A4E38D932DTest; urn:issn:0028-0836; https://serval.unil.ch/resource/serval:BIB_D3A4E38D932D.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_D3A4E38D932D3Test
الإتاحة: https://doi.org/10.1038/s41586-022-05192-0Test
https://serval.unil.ch/notice/serval:BIB_D3A4E38D932DTest
https://serval.unil.ch/resource/serval:BIB_D3A4E38D932D.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_D3A4E38D932D3Test -
2دورية أكاديمية
المؤلفون: Shaabani, Shabnam, Gadina, Louis, Surmiak, Ewa, Wang, Zefeng, Zhang, Bidong, Butera, Roberto, Zarganes-Tzitzikas, Tryfon, Rodriguez, Ismael, Kocik-Krol, Justyna, Magiera-Mularz, Katarzyna, Skalniak, Lukasz, Dömling, Alexander, Holak, Tad A
المصدر: Shaabani , S , Gadina , L , Surmiak , E , Wang , Z , Zhang , B , Butera , R , Zarganes-Tzitzikas , T , Rodriguez , I , Kocik-Krol , J , Magiera-Mularz , K , Skalniak , L , Dömling , A & Holak , T A 2022 , ' Biphenyl Ether Analogs Containing Pomalidomide as Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction ' , Molecules , vol. 27 , no. 11 , 3454 . https://doi.org/10.3390/molecules27113454Test
مصطلحات موضوعية: B7-H1 Antigen/antagonists & inhibitors, Biphenyl Compounds, Humans, Ligands, Programmed Cell Death 1 Receptor/antagonists & inhibitors, Thalidomide/analogs & derivatives
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.3390/molecules27113454Test
https://hdl.handle.net/11370/e1e3fe2e-cfea-4d37-990e-bdd42bba66b4Test
https://research.rug.nl/en/publications/e1e3fe2e-cfea-4d37-990e-bdd42bba66b4Test
https://pure.rug.nl/ws/files/226292612/molecules_27_03454.pdfTest -
3دورية أكاديمية
المؤلفون: Doki, Yuichiro, Ajani, Jaffer A., Kato, Ken, Xu, Jianming, Wyrwicz, Lucjan, Motoyama, Satoru, Ogata, Takashi, Kawakami, Hisato, Hsu, Chih Hung, Adenis, Antoine, El Hajbi, Farid, Di Bartolomeo, Maria, Braghiroli, Maria I., Holtved, Eva, Ostoich, Sandra A., Kim, Hye R., Ueno, Masaki, Mansoor, Wasat, Yang, Wen Chi, Liu, Tianshu, Bridgewater, John, Makino, Tomoki, Xynos, Ioannis, Liu, Xuan, Lei, Ming, Kondo, Kaoru, Patel, Apurva, Gricar, Joseph, Chau, Ian, Kitagawa, Yuko
المصدر: Doki , Y , Ajani , J A , Kato , K , Xu , J , Wyrwicz , L , Motoyama , S , Ogata , T , Kawakami , H , Hsu , C H , Adenis , A , El Hajbi , F , Di Bartolomeo , M , Braghiroli , M I , Holtved , E , Ostoich , S A , Kim , H R , Ueno , M , Mansoor , W , Yang , W C , Liu , T , Bridgewater , J , Makino , T , Xynos , I ....
مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols/adverse effects, B7-H1 Antigen/antagonists & inhibitors, Carcinoma, Squamous Cell/drug therapy, Esophageal Neoplasms/drug therapy, Female, Humans, Immune Checkpoint Inhibitors/administration & dosage, Ipilimumab/administration & dosage, Male, Middle Aged, Nivolumab/administration & dosage, Progression-Free Survival, Survival Analysis
وصف الملف: application/pdf
العلاقة: https://portal.findresearcher.sdu.dk/da/publications/76f3939c-aaec-43dc-b929-d332bb705979Test
الإتاحة: https://doi.org/10.1056/NEJMoa2111380Test
https://portal.findresearcher.sdu.dk/da/publications/76f3939c-aaec-43dc-b929-d332bb705979Test
https://findresearcher.sdu.dk/ws/files/203733054/nejmoa2111380.pdfTest -
4دورية أكاديمية
المساهمون: Bradley J Monk, Nicoletta Colombo, Amit M Oza, Keiichi Fujiwara, Michael J Birrer, Leslie Randall, Elena V Poddubskaya, Giovanni Scambia, Yaroslav V Shparyk, Myong Cheol Lim, Snehalkumar M Bhoola, Joohyuk Sohn, Kan Yonemori, Ross A Stewart, Xiaoxi Zhang, Julia Perkins Smith, Carlos Linn, Jonathan A Ledermann, Sohn, Joo Hyuk
مصطلحات موضوعية: Aged, Antibodies, Monoclonal, Humanized / therapeutic use, Antineoplastic Agents, Immunological / therapeutic use, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, B7-H1 Antigen / antagonists & inhibitors, B7-H1 Antigen / metabolism, Carcinoma, Ovarian Epithelial / drug therapy, Ovarian Epithelial / pathology, Drug-Related Side Effects and Adverse Reactions, Female, Humans, Immune Checkpoint Inhibitors / therapeutic use, Maintenance Chemotherapy, Middle Aged, Ovarian Neoplasms / drug therapy, Ovarian Neoplasms / metabolism, Ovarian Neoplasms / pathology, Progression-Free Survival
العلاقة: LANCET ONCOLOGY; J02154; OAK-2022-04735; OAK-2022-08779; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190540Test; https://www.sciencedirect.com/science/article/pii/S1470204521003429Test; T999202160; LANCET ONCOLOGY, Vol.22(9) : 1275-1289, 2021-09
الإتاحة: https://doi.org/10.1016/S1470-2045Test(21)00342-9
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190540Test
https://www.sciencedirect.com/science/article/pii/S1470204521003429Test -
5دورية أكاديمية
المساهمون: Chia-Chi Lin, Toshihiko Doi, Kei Muro, Ming-Mo Hou, Taito Esaki, Hiroki Hara, Hyun Cheol Chung, Christoph Helwig, Isabelle Dussault, Motonobu Osada, Shunsuke Kondo, Chung, Hyun Cheol
مصطلحات موضوعية: Adult, Aged, 80 and over, Asia, B7-H1 Antigen / antagonists & inhibitors, Esophageal Neoplasms / drug therapy, Esophageal Squamous Cell Carcinoma / drug therapy, Female, Humans, Male, Middle Aged, Transforming Growth Factor beta / antagonists & inhibitors
العلاقة: TARGETED ONCOLOGY; J03951; OAK-2022-05004; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190870Test; T9992022281; TARGETED ONCOLOGY, Vol.16(4) : 447-459, 2021-07
الإتاحة: https://doi.org/10.1007/s11523-021-00810-9Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190870Test -
6دورية أكاديمية
المساهمون: Changhoon Yoo, Do-Youn Oh, Hye Jin Choi, Masatoshi Kudo, Makoto Ueno, Shunsuke Kondo, Li-Tzong Chen, Motonobu Osada, Christoph Helwig, Isabelle Dussault, Masafumi Ikeda, Choi, Hye Jin
مصطلحات موضوعية: Adult, Aged, Antineoplastic Agents, Immunological / administration & dosage, Immunological / adverse effects, B7-H1 Antigen / antagonists & inhibitors, B7-H1 Antigen / immunology, Biliary Tract Neoplasms / drug therapy, Biliary Tract Neoplasms / immunology, Biliary Tract Neoplasms / mortality, Female, Humans, Immunoconjugates / administration & dosage, Immunoconjugates / adverse effects, Immunoconjugates / genetics, Male, Middle Aged, Progression-Free Survival, Receptor, Transforming Growth Factor-beta Type II / genetics, Recombinant Fusion Proteins / administration & dosage, Recombinant Fusion Proteins / adverse effects, Recombinant Fusion Proteins / genetics, Signal Transduction / drug effects, Signal Transduction / immunology, Transforming Growth Factor beta / antagonists & inhibitors, Transforming Growth Factor beta / metabolism, Young Adult, gastrointestinal neoplasms, immunotherapy
العلاقة: JOURNAL FOR IMMUNOTHERAPY OF CANCER; J03617; OAK-2021-02662; https://ir.ymlib.yonsei.ac.kr/handle/22282913/183954Test; T202007285; JOURNAL FOR IMMUNOTHERAPY OF CANCER, Vol.8(1) : e000564, 2020-05
الإتاحة: https://doi.org/10.1136/jitc-2020-000564Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/183954Test -
7دورية أكاديمية
المساهمون: Yong Joon Kim, Jihei Sara Lee, Junwon Lee, Sung Chul Lee, Tae-Im Kim, Suk Ho Byeon, Christopher Seungkyu Lee, Kim, Yong Joon
مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Agents, Immunological / adverse effects, Antineoplastic Combined Chemotherapy Protocols / adverse effects, B7-H1 Antigen / antagonists & inhibitors, B7-H1 Antigen / immunology, CTLA-4 Antigen / antagonists & inhibitors, CTLA-4 Antigen / immunology, Drug Substitution / adverse effects, Eye Diseases / chemically induced, Eye Diseases / epidemiology, Eye Diseases / immunology, Female, Humans, Male, Middle Aged, Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors, Neoplasms / drug therapy, Neoplasms / immunology, Programmed Cell Death 1 Receptor / antagonists & inhibitors, Programmed Cell Death 1 Receptor / immunology, Protein Kinase Inhibitors / adverse effects, Proto-Oncogene Proteins B-raf / antagonists & inhibitors, Retrospective Studies, Risk Factors, Immune checkpoint inhibitor, Intraocular inflammation, Ocular adverse event
العلاقة: CANCER IMMUNOLOGY IMMUNOTHERAPY; J00445; OAK-2021-02466; https://ir.ymlib.yonsei.ac.kr/handle/22282913/183839Test; https://link.springer.com/article/10.1007%2Fs00262-020-02635-3Test; T202007144; CANCER IMMUNOLOGY IMMUNOTHERAPY, Vol.69 : 2441-2452, 2020-12
الإتاحة: https://doi.org/10.1007/s00262-020-02635-3Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/183839Test -
8دورية أكاديمية
المؤلفون: Payrat, J. A., Du, Cugnet-Anceau, C., Maillet, D., Levy, M., Raverot, G., Disse, E., Borson-Chazot, F.
المساهمون: Fédération d'Endocrinologie, Hospices Civils de Lyon (HCL), Institut de Cancérologie Hospices civils de Lyon, Département Endocrinologie-Diabétologie-Maladies Nutritionnelles Lyon-Sud, Centre Hospitalier Lyon Sud CHU - HCL (CHLS), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Centre de recherche en neurosciences de Lyon - Lyon Neuroscience Research Center (CRNL), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)
المصدر: ISSN: 0007-4551.
مصطلحات موضوعية: Humans, Risk Factors, Magnetic Resonance Imaging, Immunotherapy, Immunotherapy/*adverse effects, Neoplasms/*therapy, Immunothérapie, ACTH deficiency, Adrenal Cortex Hormones/therapeutic use, B7-H1 Antigen/antagonists & inhibitors, Checkpoint inhibiteurs, Checkpoint inhibitors, CTLA-4 Antigen/antagonists & inhibitors, Déficit corticotrope, Hyponatremia/etiology, Hypophysite, Hypophysitis, Hypophysitis/diagnostic imaging/drug therapy/*etiology, Programmed Cell Death 1 Receptor/antagonists & inhibitors, [SDV]Life Sciences [q-bio]
العلاقة: hal-02901888; https://hal.science/hal-02901888Test; https://hal.science/hal-02901888/documentTest; https://hal.science/hal-02901888/file/S0007455120301168.pdfTest; PII: S0007-4551(20)30116-8
الإتاحة: https://doi.org/10.1016/j.bulcan.2020.01.012Test
https://hal.science/hal-02901888Test
https://hal.science/hal-02901888/documentTest
https://hal.science/hal-02901888/file/S0007455120301168.pdfTest -
9دورية أكاديمية
المؤلفون: Domchek, Susan M, Postel-Vinay, Sophie, Im, Seock-Ah, Park, Yeon Hee, Delord, Jean-Pierre, Italiano, Antoine, Alexandre, Jerome, You, Benoit, Bastian, Sara, Krebs, Matthew G, Wang, Ding, Waqar, Saiama N, Lanasa, Mark, Rhee, Joon, Gao, Haiyan, Rocher-Ros, Vidalba, Jones, Emma V, Gulati, Sakshi, Coenen-Stass, Anna, Kozarewa, Iwanka, Lai, Zhongwu, Angell, Helen K, Opincar, Laura, Herbolsheimer, Pia, Kaufman, Bella
المصدر: Domchek , S M , Postel-Vinay , S , Im , S-A , Park , Y H , Delord , J-P , Italiano , A , Alexandre , J , You , B , Bastian , S , Krebs , M G , Wang , D , Waqar , S N , Lanasa , M , Rhee , J , Gao , H , Rocher-Ros , V , Jones , E V , Gulati , S , Coenen-Stass , A , Kozarewa , I , Lai , Z , Angell , H K , Opincar , L , Herbolsheimer ....
مصطلحات موضوعية: Adolescent, Adult, Aged, Antibodies, Monoclonal/administration & dosage, B7-H1 Antigen/antagonists & inhibitors, BRCA1 Protein/genetics, BRCA2 Protein/genetics, Breast Neoplasms/drug therapy, Female, Germ-Line Mutation/genetics, Humans, Middle Aged, Neoplasm Metastasis, Neoplasm Recurrence, Local/drug therapy, Phthalazines/administration & dosage, Piperazines/administration & dosage, Young Adult, ResearchInstitutes_Networks_Beacons/mcrc, name=Manchester Cancer Research Centre
وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document
الإتاحة: https://doi.org/10.1016/S1470-2045Test(20)30324-7
https://research.manchester.ac.uk/en/publications/5e0b81c7-c58f-4a44-98f4-47d6ec2731f4Test
https://pure.manchester.ac.uk/ws/files/178100696/MEDIOLA_breast_cancer_manuscript_FINAL1.docxTest -
10دورية أكاديمية
المؤلفون: Franchina, Davide G, He, Feng, BRENNER, Dirk
المصدر: Cancer Letters, 412, 216 - 223 (2018-01-01)
مصطلحات موضوعية: Anti-tumor response, Metabolic reprogramming, Metabolism, T cell, Tumor microenvironment, B7-H1 Antigen, PDCD1 protein, human, Programmed Cell Death 1 Receptor, Reactive Oxygen Species, B7-H1 Antigen/antagonists & inhibitors, Energy Metabolism, Glycolysis, Humans, Immunotherapy, Neoplasms/immunology, Programmed Cell Death 1 Receptor/physiology, Reactive Oxygen Species/metabolism, T-Lymphocytes/metabolism, Tumor Escape, Neoplasms, T-Lymphocytes, Oncology, Cancer Research, Human health sciences, Sciences de la santé humaine, Oncologie
العلاقة: https://api.elsevier.com/content/article/PII:S0304383517306493?httpAccept=text/xmlTest; urn:issn:0304-3835; urn:issn:1872-7980; https://orbilu.uni.lu/handle/10993/57931Test; info:hdl:10993/57931; https://orbilu.uni.lu/bitstream/10993/57931/1/Franchina%20et%20al_Cancer%20Letters%202018.pdfTest; scopus-id:2-s2.0-85032732530; info:pmid:29074426; wos:000418109100022
الإتاحة: https://doi.org/10.1016/j.canlet.2017.10.014Test
https://orbilu.uni.lu/handle/10993/57931Test
https://orbilu.uni.lu/bitstream/10993/57931/1/Franchina%20et%20al_Cancer%20Letters%202018.pdfTest